D-serine and the therapeutic challenge posed by the N-methyl-D-aspartate antagonist model of schizophrenia.
Krystal
J H
JH
D'Souza
D C
DC
D005998:Glycine / Q000627:therapeutic use*; D006801:Humans; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism*; D012694:Serine / Q000378:metabolism*
D016194:Receptors, N-Methyl-D-Aspartate; D012694:Serine; D016202:N-Methylaspartate; D005998:Glycine